Nola Cecins1, Elizabeth Geelhoed, Sue C Jenkins. 1. Physiotherapy Department, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, Perth, WA 6009, Australia. Nola.Cecins@health.wa.gov.au
Abstract
OBJECTIVES: Pulmonary rehabilitation (PR) improves exercise capacity and health-related quality of life (HRQoL), and reduces health care utilisation. This study quantified outcomes of a PR program over a 6-year period and determined the effects of PR on hospitalisation. METHODS: Patients with chronic obstructive pulmonary disesae (COPD) who entered an 8-week outpatient PR program from 1998 to 2003 were included. Functional exercise capacity (6-minute walk distance [6MWD]) and HRQoL (Chronic Respiratory Disease Questionnaire) were measured before and following PR. The number of hospital admissions and total bed-days due to a COPD exacerbation in the 12 months before and following PR were recorded. SETTING: Physiotherapy Department, Sir Charles Gairdner Hospital, Western Australia. RESULTS: 187 (73%) of the 256 patients who entered PR completed the program. Improvements in 6MWD (404.2 +/- 114.6 m to 439.6 +/- 115.0m, P < 0.001) and HRQoL (4.1 +/- 0.9 points per item to 4.9 +/- 0.9 points per item, P < 0.001) occurred following PR. There was a 46% reduction in the number of patients admitted to hospital (71 to 38) with a COPD exacerbation and a 62% reduction in total bed-days (1131 to 432) following PR. CONCLUSION: Pulmonary rehabilitation provided in an Australian teaching hospital was associated with a reduction in COPD hospitalisation, and the resultant savings outweighed the costs of providing the program.
OBJECTIVES: Pulmonary rehabilitation (PR) improves exercise capacity and health-related quality of life (HRQoL), and reduces health care utilisation. This study quantified outcomes of a PR program over a 6-year period and determined the effects of PR on hospitalisation. METHODS:Patients with chronic obstructive pulmonary disesae (COPD) who entered an 8-week outpatient PR program from 1998 to 2003 were included. Functional exercise capacity (6-minute walk distance [6MWD]) and HRQoL (Chronic Respiratory Disease Questionnaire) were measured before and following PR. The number of hospital admissions and total bed-days due to a COPD exacerbation in the 12 months before and following PR were recorded. SETTING: Physiotherapy Department, Sir Charles Gairdner Hospital, Western Australia. RESULTS: 187 (73%) of the 256 patients who entered PR completed the program. Improvements in 6MWD (404.2 +/- 114.6 m to 439.6 +/- 115.0m, P < 0.001) and HRQoL (4.1 +/- 0.9 points per item to 4.9 +/- 0.9 points per item, P < 0.001) occurred following PR. There was a 46% reduction in the number of patients admitted to hospital (71 to 38) with a COPD exacerbation and a 62% reduction in total bed-days (1131 to 432) following PR. CONCLUSION: Pulmonary rehabilitation provided in an Australian teaching hospital was associated with a reduction in COPD hospitalisation, and the resultant savings outweighed the costs of providing the program.
Authors: Annemarie L Lee; Nola Cecins; Catherine J Hill; Anne E Holland; Linda Rautela; Robert G Stirling; Phillip J Thompson; Christine F McDonald; Sue Jenkins Journal: BMC Pulm Med Date: 2010-02-02 Impact factor: 3.317
Authors: Rebecca T Disler; Sally C Inglis; Phillip J Newton; David C Currow; Peter S Macdonald; Allan R Glanville; DorAnne Donesky; Virginia Carrieri-Kohlman; Patricia M Davidson Journal: Interact J Med Res Date: 2015-03-06
Authors: Jennifer A Alison; Zoe J McKeough; Sue C Jenkins; Anne E Holland; Kylie Hill; Norman R Morris; Regina W M Leung; Kathleen A Williamson; Lissa M Spencer; Catherine J Hill; Annemarie L Lee; Helen Seale; Nola Cecins; Christine F McDonald Journal: BMC Pulm Med Date: 2016-02-04 Impact factor: 3.317
Authors: Narelle S Cox; Christine F McDonald; Jennifer A Alison; Ajay Mahal; Richard Wootton; Catherine J Hill; Janet Bondarenko; Heather Macdonald; Paul O'Halloran; Paolo Zanaboni; Ken Clarke; Deidre Rennick; Kaye Borgelt; Angela T Burge; Aroub Lahham; Bruna Wageck; Hayley Crute; Pawel Czupryn; Amanda Nichols; Anne E Holland Journal: BMC Pulm Med Date: 2018-05-15 Impact factor: 3.317